141PD: Whole body and intracranial efficacy of ceritinib in patients (pts) with crizotinib (CRZ) pretreated, ALK-rearranged (ALK+) non-small cell lung cancer (NSCLC) and baseline brain metastases (BM): Results from ASCEND-1 and ASCEND-2 trials

Enriqueta Felip, L. Crinò, D.-W. Kim, David R. Spigel, Makoto Nishio, Tony Mok, Giorgio V. Scagliotti, Dajana Cesic, Santosh Sutradhar, Alice T. Shaw

Journal of Thoracic Oncology · 2016 · 19 citations · 0 references

DOIFull text

Open access

Concepts